title: Epidemic Stevens-Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy?
authors.forename: Inés
authors.initials: I
authors.lastname: Oliveira
authors.forename: Søren
authors.initials: S
authors.lastname: Jensen-Fangel
authors.forename: David
authors.initials: D
authors.lastname: da Silva
authors.forename: Agostinho
authors.initials: A
authors.lastname: Ndumba
authors.forename: Candida
authors.initials: C
authors.lastname: Medina
authors.forename: Albino
authors.initials: A
authors.lastname: Nanadje
authors.forename: Dlama N
authors.initials: DN
authors.lastname: Rasmussen
authors.forename: Frauke
authors.initials: F
authors.lastname: Rudolf
authors.forename: Christian
authors.initials: C
authors.lastname: Wejse
authors.forename: Zacarias J
authors.initials: ZJ
authors.lastname: da Silva
authors.forename: Morten
authors.initials: M
authors.lastname: Sodemann
authors.forename: Alex L
authors.initials: AL
authors.lastname: Laursen
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000600:supply & distribution; D058872:Epidemics; D005260:Female; D006169:Guinea-Bissau / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine